Quality-of-Life Outcomes following Surgical Treatment of Ménière’s Disease: A Systematic Review and Meta-analysis

2018 ◽  
Vol 160 (2) ◽  
pp. 232-238 ◽  
Author(s):  
Daniel P. Ballard ◽  
Daniel C. Sukato ◽  
Alisa Timashpolsky ◽  
Seilesh C. Babu ◽  
Richard M. Rosenfeld ◽  
...  

Objective Several surgical interventions are offered to patients with Ménière’s disease (MD) who fail medical management. Although outcomes have historically been reported according to American Academy of Otolaryngology—Head and Neck Surgery guidelines, patient-reported outcome measures (PROMs) are increasingly used to evaluate treatments. This study reviews PROMs used to assess surgical treatments for MD and compares the effect of each intervention based on PROM scores. Data Sources PubMed, EMBASE, CINAHL, and Web of Science. Review Methods This is a systematic review and meta-analysis of English-language studies that reported PROMs for surgical treatments of MD. Two independent investigators assessed study eligibility, rated the quality using Methodological Index for Non-Randomized Studies (MINORS), and abstracted data for comparative analysis. A random-effects model was used for meta-analysis of pooled data. Results Of 148 unique studies identified, 11 satisfied inclusion criteria. The Ménière’s Disease Outcome Questionnaire (MDOQ) was the most commonly used survey. Interventions included intratympanic gentamicin, vestibular nerve section, endolymphatic sac surgery, and labyrinthectomy. Pooled analysis of 8 studies that used the MDOQ instrument demonstrated statistically significant improvements in quality of life but did not identify a difference between destructive and nondestructive procedures. Conclusion Although our review shows significant improvements in PROM scores for both destructive and nondestructive interventions, there was no significant difference noted between treatment types. We cannot draw conclusions regarding the comparative effectiveness of specific interventions, and the results do not account for placebo effects or the natural history of the disease. Further investigation with randomized controlled trials should be considered in future studies.

2004 ◽  
Vol 131 (2) ◽  
pp. P153-P153
Author(s):  
Fernando F Gananca ◽  
Fabiana Cunha ◽  
Flavio Parente Settani ◽  
Anne Marbella ◽  
Katherine B. Myers ◽  
...  

2012 ◽  
Vol 33 (8) ◽  
pp. 1380-1385 ◽  
Author(s):  
Martin Schlegel ◽  
Dominique Vibert ◽  
Sebastian R. Ott ◽  
Rudolf Häusler ◽  
Marco Domenico Caversaccio

Author(s):  
J L Liu ◽  
J G Liu ◽  
X B Chen ◽  
Y H Liu

Abstract Objective This study aimed to evaluate the benefits of betahistine or vestibular rehabilitation (Tetrax biofeedback) on the quality of life and fall risk in patients with Ménière's disease. Methods Sixty-six patients with Ménière's disease were randomly divided into three groups: betahistine, Tetrax and control groups. Patients’ Dizziness Handicap Index and Tetrax fall index scores were obtained before and after treatment. Results Patients in the betahistine and Tetrax groups showed significant improvements in Dizziness Handicap Index and fall index scores after treatment versus before treatment (p < 0.05). The improvements in the Tetrax group were significantly greater than those in the betahistine group (p < 0.05). Conclusions Betahistine and vestibular rehabilitation (Tetrax biofeedback) improve the quality of life and reduce the risk of falling in patients with Ménière's disease. Vestibular rehabilitation (Tetrax biofeedback) is an effective management method for Ménière's disease.


Sign in / Sign up

Export Citation Format

Share Document